110 related articles for article (PubMed ID: 8369231)
1. The clinical relevance of an auditory attention task (PAT) in a longitudinal study of chronic schizophrenia, with placebo substitution for chlorpromazine.
Pigache RM
Schizophr Res; 1993 Jun; 10(1):39-50. PubMed ID: 8369231
[TBL] [Abstract][Full Text] [Related]
2. Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study.
Pigache RM
Schizophr Res; 1993 Jun; 10(1):51-9. PubMed ID: 8369232
[TBL] [Abstract][Full Text] [Related]
3. Auditory sustained attention in schizophrenia: a comparison of the Continuous Performance Test and the Pigache Attention Task.
Pigache RM
Psychiatry Res; 1996 Mar; 60(2-3):155-65. PubMed ID: 8723306
[TBL] [Abstract][Full Text] [Related]
4. Laterality, attention and rate effects in the auditory temporal discrimination of chronic schizophrenics: the effect of treatment with chlorpromazine.
Hammond NV; Gruzelier JH
Q J Exp Psychol; 1978 Feb; 30(1):91-103. PubMed ID: 345319
[No Abstract] [Full Text] [Related]
5. The effects of antipsychotic drugs and symptomatology on perceptual asymmetry in schizophrenia.
Carr V; Wale J
J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1531-7. PubMed ID: 2906089
[TBL] [Abstract][Full Text] [Related]
6. Lateralized deficits and drug influences on the dichotic listening of schizophrenic patients.
Gruzelier JH; Hammond NV
Biol Psychiatry; 1980 Oct; 15(5):759-79. PubMed ID: 7417630
[TBL] [Abstract][Full Text] [Related]
7. The effect of illness duration on perceptual asymmetry in schizophrenia.
Carr V; Wale J; Dewis S; Stephan L
Schizophr Res; 1992 Sep; 7(3):211-6. PubMed ID: 1356424
[TBL] [Abstract][Full Text] [Related]
8. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G
J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.
Bergemann N; Parzer P; Jaggy S; Auler B; Mundt C; Maier-Braunleder S
Schizophr Bull; 2008 Nov; 34(6):1172-81. PubMed ID: 18156639
[TBL] [Abstract][Full Text] [Related]
10. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia.
Zahn TP; Pickar D; Haier RJ
Schizophr Res; 1994 Sep; 13(2):133-44. PubMed ID: 7986770
[TBL] [Abstract][Full Text] [Related]
11. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
Stefánsson SB; Jónsdóttir TJ
Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
[TBL] [Abstract][Full Text] [Related]
12. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
13. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
Shopsin B; Klein H; Aaronsom M; Collora M
Arch Gen Psychiatry; 1979 Jun; 36(6):657-64. PubMed ID: 375865
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of butaclamol in chronic schizophrenic patients.
Clark ML; Paredes A; Costiloe JP; Wood F
J Clin Pharmacol; 1977; 17(8-9):529-36. PubMed ID: 19510
[TBL] [Abstract][Full Text] [Related]
15. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
[No Abstract] [Full Text] [Related]
16. Comparison of pimozide and chlorpromazine in acute schizophrenia.
Pecknold JC; McClure DJ; Allan T; Wrzesinski L
Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898
[TBL] [Abstract][Full Text] [Related]
17. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics.
Spohn HE; Lacoursiere RB; Thompson K; Coyne L
Arch Gen Psychiatry; 1977 Jun; 34(6):633-44. PubMed ID: 326215
[TBL] [Abstract][Full Text] [Related]
18. Listening, priming and emotion under a neuroleptic drug.
Hartley LR; Serna P; Arnold PK; Mulligan B
Physiol Behav; 1990 May; 47(5):837-41. PubMed ID: 2388939
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
[TBL] [Abstract][Full Text] [Related]
20. Auditory attention in process and reactive schizophrenia.
Maloney MP; Sloane RB; Whipple K; Rzani J; Eaton EM
Biol Psychiatry; 1976 Jun; 11(3):325-32. PubMed ID: 779856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
